Food lovers around the world are preparing for a taste revolution in 2025. From bold fusion flavors to inventive twists on old favorites, chefs and home cooks alike ...

Tectonic Therapeutic, Inc.'s stock surged 120% on positive Phase 1b data for TX45 in treating PH-HFpEF, offering a potential ...

Roche will continue a careful approach to high-priced deals, putting science at the center of its business development ...

Famous Malaysian hawker chain brings fusion tornado egg rice with Thai green curry to SG appeared first on SETHLUI.com.

Despite the failure of an eczema trial in December, Q32 Bio is sticking with bempikibart. But a phase 2-stage complement inhibitor and a number of the biotech’s “valued colleagues” won’t be so lucky.

A PAT roadmap should address data analysis, aggregation, visualization, and the smart utility of those data for greater process understanding.

The two products, both manufactured by Amgen, are aflibercept biosimilars Pavblu and Skojoy. Both biosimilars are indicated ...

Hastings Family YMCA Personal Trainer has some tips on how you can stay motivated if you fall off of your routine.

With 23 to 28 grams of protein per cup (and only about 200 calories), cottage cheese can help you build muscle and lose ...

Akribion Therapeutics emerges from stealth with €8 million in seed funding to develop a novel cancer RNA-guided approach ...

Shares of Tectonic Therapeutic Inc. (NASDAQ:TECX) were trading at $55, up $29.28, or 113%, on positive interim data from the phase Ib acute hemodynamic trial of its lead product candidate, TX-45.